FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11960911000001108: Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43506501000001116 Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105856701000001116 Rasilez 150mg tablets (Noden Pharma DAC) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Aliskiren 150mg tablets true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Aliskiren 150mg tablets false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Aliskiren hemifumarate true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Rasilez true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance Aliskiren true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is pack of False Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has AMP True Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start